Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Vestergaard · SciRah

Researcher profile · Semantic Scholar

H. Vestergaard

Share profile

H. Vestergaard — researcher profile on SciRah

h-index: 29
Works: 90
Citations: 3,036

Most-cited papers

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
S. Saussele, J. Richter, J. Guilhot, F. Gruber +45 more
2018The Lancet Oncology555 citations Open access
Semantic Scholar
Epidemiology of systemic mastocytosis in Denmark
Sarah S. Cohen, Stine Skovbo, H. Vestergaard, T. Kristensen +4 more
2014British Journal of Haematology217 citations Open access
Semantic Scholar
Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.
T. Kristensen, H. Vestergaard, M. Møller
2011Journal of Molecular Diagnostics193 citations Open access
Semantic Scholar
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
H. Birgens, H. Frederiksen, H. Hasselbalch, Inge Helleberg Rasmussen +9 more
2013British Journal of Haematology174 citations Open access
Semantic Scholar
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
S. Ehmsen, Anders Asmussen, S. S. Jeppesen, A. Nilsson +6 more
2021Cancer Cell154 citations Open access
Semantic Scholar
Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis
T. Kristensen, H. Vestergaard, C. Bindslev-Jensen, Michael Boe Møller +1 more
2014American journal of hematology/oncology119 citations Open access
Semantic Scholar
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
S. Broesby-Olsen, H. Vestergaard, C. Mortz, Bo Amdi Jensen +6 more
2018Allergy. European Journal of Allergy and Clinical Immunology102 citations
Semantic Scholar
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha.
Thomas Stauffer Larsen, K. F. Iversen, E. Hansen, A. B. Mathiasen +11 more
2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis94 citations
Semantic Scholar
Autoimmune pulmonary alveolar proteinosis: Treatment options in year 2013
S. Leth, E. Bendstrup, H. Vestergaard, O. Hilberg
2013Respirology (Carlton South. Print)75 citations
Semantic Scholar
Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population‐based study
S. Broesby-Olsen, D. Farkas, H. Vestergaard, A. Hermann +6 more
2016American journal of hematology/oncology72 citations Open access
Semantic Scholar
A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia
C. Andersen, M. McMullin, E. Ejerblad, S. Zweegman +16 more
2013British Journal of Haematology72 citations
Semantic Scholar
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
F. Mahon, M. Pfirrmann, S. Dulucq, A. Hochhaus +23 more
2024Journal of Clinical Oncology60 citations Open access
Semantic Scholar
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
H. Hjorth-Hansen, J. Stentoft, J. Richter, P. Koskenvesa +16 more
2016Leukemia58 citations Open access
Semantic Scholar
Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis
T. Kristensen, S. Broesby-Olsen, H. Vestergaard, C. Bindslev-Jensen +1 more
2013European Journal of Haematology58 citations
Semantic Scholar
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
L. Möllgård, L. Saft, M. Treppendahl, I. Dybedal +14 more
2011Haematologica55 citations Open access
Semantic Scholar
Systemic mastocytosis--a systematic review.
C. Andersen, T. Kristensen, M. Severinsen, M. Møller +4 more
2012Danish Medical Journal53 citations
Semantic Scholar
Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood.
S. Broesby-Olsen, A. R. Oropeza, C. Bindslev-Jensen, H. Vestergaard +4 more
2015Journal of Allergy and Clinical Immunology49 citations Open access
Semantic Scholar
Patterns of anaphylaxis after diagnostic workup: A follow‐up study of 226 patients with suspected anaphylaxis
A. R. Oropeza, C. Bindslev-Jensen, S. Broesby-Olsen, T. Kristensen +6 more
2017Allergy. European Journal of Allergy and Clinical Immunology48 citations
Semantic Scholar
Circulating KIT D816V mutation‐positive non‐mast cells in peripheral blood are characteristic of indolent systemic mastocytosis
T. Kristensen, S. Broesby-Olsen, H. Vestergaard, C. Bindslev-Jensen +1 more
2012European Journal of Haematology48 citations
Semantic Scholar
Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population‐based cohort study
S. Farmer, E. Horváth-Puhó, H. Vestergaard, A. Hermann +1 more
2013British Journal of Haematology47 citations
Semantic Scholar
Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death
C. Andersen, V. Siersma, H. Hasselbalch, H. Lindegaard +4 more
2013American journal of hematology/oncology45 citations Open access
Semantic Scholar
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.
S. Broesby-Olsen, T. Kristensen, H. Vestergaard, K. Brixen +2 more
2013Journal of Allergy and Clinical Immunology45 citations Open access
Semantic Scholar
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).
Se Y. Han, K. Mrózek, Jenna Voutsinas, Qian Wu +43 more
2021Blood Advances43 citations Open access
Semantic Scholar
Acquired Angioedema - Occurrence, Clinical Features and Associated Disorders in a Danish Nationwide Patient Cohort
A. Bygum, H. Vestergaard
2013International Archives of Allergy and Immunology42 citations
Semantic Scholar
Trends in hematological cancer in the elderly in Denmark, 1980–2012
L. F. Ocias, T. Larsen, H. Vestergaard, L. Friis +2 more
2016Acta oncologica39 citations Open access
Semantic Scholar
Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis
T. Kristensen, H. Vestergaard, C. Bindslev-Jensen, C. Mortz +4 more
2017Allergy. European Journal of Allergy and Clinical Immunology38 citations
Semantic Scholar
Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.
S. Broesby-Olsen, I. Dybedal, Theo Gülen, T. Kristensen +21 more
2016Acta Dermato-Venereologica37 citations Open access
Semantic Scholar
The multidisciplinary approach to eosinophilia
Gunhild Nynke Thomsen, Mette Niemann Christoffersen, H. Lindegaard, J. Davidsen +14 more
2023Frontiers in Oncology32 citations Open access
Semantic Scholar
Association of the blood eosinophil count with hematological malignancies and mortality
C. Andersen, V. Siersma, H. Hasselbalch, H. Vestergaard +4 more
2015American journal of hematology/oncology29 citations Open access
Semantic Scholar
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis
C. Andersen, N. Mortensen, T. Klausen, H. Vestergaard +2 more
2014Haematologica27 citations Open access
Semantic Scholar
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms
M. Brabrand, K. N. Hansen, C. Laursen, T. Larsen +2 more
2019European Journal of Haematology26 citations Open access
Semantic Scholar
Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)
Celalettin Ustun, E. Morgan, Erica E. M. Moodie, S. Pullarkat +42 more
2018Cancer Medicine24 citations Open access
Semantic Scholar
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
M. Hoeks, T. Bagguley, C. V. van Marrewijk, Alex Smith +201 more
2020Leukemia23 citations Open access
Semantic Scholar
Risk of Lymphoma and Solid Cancer among Patients with Rheumatoid Arthritis in a Primary Care Setting
C. Andersen, H. Lindegaard, H. Vestergaard, V. Siersma +4 more
2014PLoS ONE21 citations Open access
Semantic Scholar
Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.
S. Broesby-Olsen, T. Kristensen, M. Møller, C. Bindslev-Jensen +1 more
2012Journal of Allergy and Clinical Immunology21 citations Open access
Semantic Scholar
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
F. Efficace, F. Mahon, J. Richter, A. Piciocchi +20 more
2024Leukemia16 citations Open access
Semantic Scholar
Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations – a Danish single site cross-sectional survey
Charlotte Ellehuus, S. S. Jeppesen, L. Eckhoff, H. Vestergaard +3 more
2021Acta oncologica16 citations Open access
Semantic Scholar
"Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial
S. Saussele, J. Richter, J. Guilhot, H. Hjorth-Hansen +39 more
201715 citations
Semantic Scholar
Targeted ultradeep next‐generation sequencing as a method for KIT D816V mutation analysis in mastocytosis
T. Kristensen, S. Broesby-Olsen, H. Vestergaard, C. Bindslev-Jensen +1 more
2016European Journal of Haematology14 citations
Semantic Scholar
Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.
C. Andersen, M. E. Bjørn, M. McMullin, C. Harrison +21 more
2014Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis14 citations
Semantic Scholar
Bone morbidity in chronic myeloproliferative neoplasms
S. Farmer, L. F. Ocias, H. Vestergaard, S. Broesby-Olsen +2 more
2015Expert Review of Hematology13 citations
Semantic Scholar
Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers
S. Farmer, H. Vestergaard, S. Hansen, Vikram Vinod Shanbhoque +3 more
2015International journal of hematology13 citations
Semantic Scholar
KIT D816V Mutation-Positive Cell Fractions in Lesional Skin Biopsies from Adults with Systemic Mastocytosis
T. Kristensen, S. Broesby-Olsen, H. Vestergaard, C. Bindslev-Jensen +1 more
2013Dermatology13 citations
Semantic Scholar
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study
M. P. Jørgensen, A. Øvlisen, J. F. Jensen, T. El-Galaly +4 more
2025European Journal of Epidemiology11 citations Open access
Semantic Scholar
FINAL Analysis of a PAN European STOP Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI Study
F. Mahon, J. Richter, A. Hochhaus, P. Panayiotidis +16 more
2021Blood10 citations Open access
Semantic Scholar
Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia
T. Kristensen, B. Preiss, S. Broesby-Olsen, H. Vestergaard +2 more
2012Leukemia and Lymphoma10 citations
Semantic Scholar
Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis
T. Kristensen, H. Vestergaard, C. Bindslev-Jensen, M. Møller +1 more
2019Allergy. European Journal of Allergy and Clinical Immunology9 citations Open access
Semantic Scholar
[Interaction between warfarin and oral miconazole gel].
C. G. Ogard, H. Vestergaard
2000Ugeskrift for læger9 citations
Semantic Scholar
Core-Binding Factor Acute Myeloid Leukemia with inv(16): Older Age and High White Blood Cell Count are Risk Factors for Treatment Failure
Celalettin Ustun, E. Morgan, E. Ritz, H. Vestergaard +42 more
2020International Journal of Laboratory Hematology8 citations Open access
Semantic Scholar
Comparison of gDNA‐based versus mRNA‐based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosis
T. Kristensen, S. Broesby-Olsen, H. Vestergaard, C. Bindslev-Jensen +1 more
2017British Journal of Haematology8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Broesby-Olsen×23
Invite
S. Broesby-Olsen — researcher profile on SciRah
T. Kristensen×22
Invite
T. Kristensen — researcher profile on SciRah
M. Møller×16
Invite
M. Møller — researcher profile on SciRah
C. Bindslev-Jensen×14
Invite
C. Bindslev-Jensen — researcher profile on SciRah

×11

Invite

O. Bjerrum — researcher profile on SciRah

H. Frederiksen×8

Invite

H. Frederiksen — researcher profile on SciRah

Michael Boe Møller×8

Invite

Michael Boe Møller — researcher profile on SciRah

Invite

C. Andersen — researcher profile on SciRah

Invite

C. Mortz — researcher profile on SciRah

H. Hjorth-Hansen×6

Invite

H. Hjorth-Hansen — researcher profile on SciRah

H. Hasselbalch×6

Invite

H. Hasselbalch — researcher profile on SciRah

P. Panayiotidis×5

Invite

P. Panayiotidis — researcher profile on SciRah